Hird, A.E., Magee, D.E., Cheung, D.C., Matta, R., Kulkarni, G.S. and Nam, R.K. 2020. Abiraterone vs. docetaxel for metastatic hormone-sensitive prostate cancer: A microsimulation model. Canadian Urological Association Journal. 14, 9 (Mar. 2020), E418–27. DOI:https://doi.org/10.5489/cuaj.6234.